About the Conference
Presented by the University of Wisconsin School of Medicine and Public Health, Department of Surgery, and Office of Continuing Professional Development in Medicine and Public Health, the goal of this educational activity is to examine the latest developments and current techniques in the multidisciplinary care of the patient undergoing neoadjuvant therapy for breast cancer, as well as instruction on novel approaches and clinical trials.
This daylong program is designed to educate all members of the breast team on evidence-based practices in neoadjuvant therapy for breast cancer patients.
• Patient/Provider panel
• Multidisciplinary case review and real-time case discussion
Intended Audience and Scope of Practice
This educational activity has been designed to meet the needs of breast surgeons, radiation oncologists, medical oncologists, and advanced practice providers as well as other health care professionals who care for patients with breast cancer.
Elements of Competence
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, and medical knowledge.
The University of Wisconsin School of Medicine and Public Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statements
The University of Wisconsin School of Medicine and Public Health designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin-Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 6.25 continuing education units (CEUs) or .625 hours.
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin School of Medicine and Public Health that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.
The University of Wisconsin School of Medicine and Public Health gratefully acknowledges the educational grant from Genentech in support of this educational activity.